The Myoglobin (MYO) detection kit is designed for the quantitative measurement of myoglobin levels in human serum, aiding in the diagnosis of myocardial infarction (MI) and monitoring muscle-related conditions. Using chemiluminescence immunoassay (CLIA) technology, the kit detects concentrations in the range of 1.0–1200.0 ng/mL.
The Myoglobin (MYO) Detection Kit uses chemiluminescence immunoassay (CLIA) technology to quantitatively measure myoglobin in human serum, aiding in early myocardial infarction (MI) diagnosis and muscle condition monitoring. With a detection range of 1.0–1200.0 ng/mL and compatibility with multiple analyzers, it provides rapid, sensitive results within 2–4 hours post-MI.